1. Leveraging clinical decision support tools to improve guideline-directed medical therapy in patients with atherosclerotic cardiovascular disease at hospital discharge.
- Author
-
Vani A, Kan K, Iturrate E, Levy-Lambert D, Smilowitz NR, Saxena A, Radford MJ, and Gianos E
- Subjects
- Aged, Aged, 80 and over, Female, Fibrinolytic Agents therapeutic use, Hospitals, Humans, Male, Middle Aged, Patient Discharge, Treatment Outcome, Atherosclerosis drug therapy, Cardiovascular Diseases drug therapy, Decision Support Systems, Clinical, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
- Abstract
Background: Guidelines recommend moderate to high-intensity statins and antithrombotic agents in patients with atherosclerotic cardiovascular disease (ASCVD). However, guideline-directed medical therapy (GDMT) remains suboptimal., Methods: In this quality initiative, best practice alerts (BPA) in the electronic health record (EHR) were utilized to alert providers to prescribe to GDMT upon hospital discharge in ASCVD patients. Rates of GDMT were compared for 5 months pre- and post-BPA implementation. Multivariable regression was used to identify predictors of GDMT., Results: In 5985 pre- and 5568 post-BPA patients, the average age was 69.1 ± 12.8 years and 58.5% were male. There was a 4.0% increase in statin use from 67.3% to 71.3% and a 3.1% increase in antithrombotic use from 75.3% to 78.4% in the post-BPA cohort., Conclusions: This simple EHR-based initiative was associated with a modest increase in ASCVD patients being discharged on GDMT. Leveraging clinical decision support tools provides an opportunity to influence provider behavior and improve care for ASCVD patients, and warrants further investigation.
- Published
- 2022
- Full Text
- View/download PDF